Loading clinical trials...
Loading clinical trials...
This test took the target lesion restenosis rate 6 months after the operation as the main endpoint to verify the effectiveness of the intracranial balloon expansion catheter of Biolimus coating. After...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bochang
Collaborators
NCT07197970 · Symptomatic Intracranial Atherosclerotic Stenosis
NCT05907629 · Stroke, Intracranial Atherosclerotic Stenosis (ICAS)
NCT07156344 · Asymptomatic Intracranial Atherosclerotic Stenosis Patients
NCT07133451 · Intracranial Atherosclerotic Stenosis
NCT06052020 · Stroke, Intracranial Atherosclerotic Stenosis
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions